TapewireFind a company

person · Reporting owner

COLLIER RICHARD T

Disclosed activity across 1 company

Tapewire entity
47033
SEC CIK
0001110751

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
PROTHENA CORP PUBLIC LTD COPRTA · Entity 2375DirectorMay 15, 2026May 16, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

PROTHENA CORP PUBLIC LTD CO

Report date May 15, 2026 · Filed May 16, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.76 · Expires 2036-05-15Direct27,000 Reported balance After 2026-05-15 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-05-15 · Grant · Acquired 27,000 · Balance 27,000

F1: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2027 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2027 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 15, 2026 Filed May 16, 2026 01:28 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 27,000 $0.00 Strike: $9.76 $0.00
Disclosure

SEC source: 0000905148-26-002466 · form4.xml · derivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,000

Underlying: Ordinary Shares · 27,000 shares

Expires 2036-05-15

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2027 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.

Read SEC document
May 14, 2025 Filed May 16, 2025 20:46 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 20,183 $0.00 Strike: $6.89 $0.00
Disclosure

SEC source: 0000905148-25-001827 · form4.xml · derivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,183

Underlying: Ordinary Shares · 20,183 shares

Expires 2035-05-14

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2026 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.

Read SEC document
May 15, 2024 Filed May 17, 2024 20:31 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $22.39 $0.00
Disclosure

SEC source: 0000905148-24-001530 · form4.xml · derivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Ordinary Shares · 15,000 shares

Expires 2034-05-15

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2025 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.

Read SEC document
May 17, 2023 Filed May 20, 2023 01:31 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $76.00 $0.00
Disclosure

SEC source: 0001140361-23-025830 · form4.xml · derivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Ordinary Shares · 15,000 shares

Expires 2033-05-17

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2024 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 02:38 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $6.41 $0.00
Disclosure

SEC source: 0001567619-23-000573 · doc1.xml · derivative · entry 3

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 5,000 shares

Expires 2023-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023.

F3 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option would have expired in approximately one month and would have been forfeited to the extent it was not exercised on or prior to January 29, 2023.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 02:38 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 5,000 $52.67 $263,350.00
Disclosure

SEC source: 0001567619-23-000573 · doc1.xml · nonDerivative · entry 2

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,219

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $52.215 to $53.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 2 of this Form 4.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 02:38 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 5,000 $6.41 $32,050.00
Disclosure

SEC source: 0001567619-23-000573 · doc1.xml · nonDerivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 05, 2022 Filed Dec 6, 2022 02:47 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $6.41 $0.00
Disclosure

SEC source: 0001567619-22-021312 · doc1.xml · derivative · entry 7

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Ordinary Shares · 5,000 shares

Expires 2023-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately two months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.

F7 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately two months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.

Read SEC document
December 05, 2022 Filed Dec 6, 2022 02:47 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 949 $65.02 $61,701.13
Disclosure

SEC source: 0001567619-22-021312 · doc1.xml · nonDerivative · entry 6

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,219

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F6 · price: The transaction was executed in multiple trades in prices ranging from $64.66 to $65.62, inclusive.

Read SEC document
December 05, 2022 Filed Dec 6, 2022 02:47 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 647 $63.83 $41,295.87
Disclosure

SEC source: 0001567619-22-021312 · doc1.xml · nonDerivative · entry 5

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,168

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The transaction was executed in multiple trades in prices ranging from $63.465 to $64.145, inclusive.

Read SEC document
December 05, 2022 Filed Dec 6, 2022 02:47 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 576 $62.71 $36,121.13
Disclosure

SEC source: 0001567619-22-021312 · doc1.xml · nonDerivative · entry 4

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,815

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $62.19 to $63.06, inclusive.

Read SEC document
December 05, 2022 Filed Dec 6, 2022 02:47 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 913 $61.13 $55,808.59
Disclosure

SEC source: 0001567619-22-021312 · doc1.xml · nonDerivative · entry 3

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,391

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $60.87 to $61.65, inclusive.

Read SEC document
December 05, 2022 Filed Dec 6, 2022 02:47 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 1,915 $60.28 $115,429.31
Disclosure

SEC source: 0001567619-22-021312 · doc1.xml · nonDerivative · entry 2

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,304

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $59.72 to $60.67, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 6 of this Form 4.

Read SEC document
December 05, 2022 Filed Dec 6, 2022 02:47 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 5,000 $6.41 $32,050.00
Disclosure

SEC source: 0001567619-22-021312 · doc1.xml · nonDerivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 07, 2022 Filed Nov 10, 2022 02:30 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $6.41 $0.00
Disclosure

SEC source: 0001567619-22-019408 · doc1.xml · derivative · entry 5

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Ordinary Shares · 5,000 shares

Expires 2023-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately three months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.

F5 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately three months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.

Read SEC document
November 07, 2022 Filed Nov 10, 2022 02:30 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 826 $56.89 $46,995.02
Disclosure

SEC source: 0001567619-22-019408 · doc1.xml · nonDerivative · entry 4

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,219

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $56.37 to $57.23, inclusive.

Read SEC document
November 07, 2022 Filed Nov 10, 2022 02:30 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 2,688 $55.71 $149,739.88
Disclosure

SEC source: 0001567619-22-019408 · doc1.xml · nonDerivative · entry 3

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,045

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $55.29 to $56.27, inclusive.

Read SEC document
November 07, 2022 Filed Nov 10, 2022 02:30 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 1,486 $54.74 $81,348.25
Disclosure

SEC source: 0001567619-22-019408 · doc1.xml · nonDerivative · entry 2

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,733

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $54.29 to $55.195, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 4 of this Form 4.

Read SEC document
November 07, 2022 Filed Nov 10, 2022 02:30 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 5,000 $6.41 $32,050.00
Disclosure

SEC source: 0001567619-22-019408 · doc1.xml · nonDerivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 05, 2022 Filed Oct 8, 2022 01:36 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $6.41 $0.00
Disclosure

SEC source: 0001567619-22-018377 · doc1.xml · derivative · entry 6

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Ordinary Shares · 5,000 shares

Expires 2023-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.

F6 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.

Read SEC document
October 05, 2022 Filed Oct 8, 2022 01:36 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 354 $59.95 $21,221.80
Disclosure

SEC source: 0001567619-22-018377 · doc1.xml · nonDerivative · entry 5

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,219

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The transaction was executed in multiple trades in prices ranging from $59.90 to $60.00, inclusive.

Read SEC document
October 05, 2022 Filed Oct 8, 2022 01:36 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 352 $58.94 $20,747.51
Disclosure

SEC source: 0001567619-22-018377 · doc1.xml · nonDerivative · entry 4

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,573

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $58.585 to $59.30, inclusive.

Read SEC document
October 05, 2022 Filed Oct 8, 2022 01:36 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 3,404 $57.97 $197,333.62
Disclosure

SEC source: 0001567619-22-018377 · doc1.xml · nonDerivative · entry 3

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,925

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $57.53 to $58.48, inclusive.

Read SEC document
October 05, 2022 Filed Oct 8, 2022 01:36 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 890 $56.54 $50,318.82
Disclosure

SEC source: 0001567619-22-018377 · doc1.xml · nonDerivative · entry 2

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,329

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $56.37 to $56.87, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 5 of this Form 4.

Read SEC document
October 05, 2022 Filed Oct 8, 2022 01:36 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 5,000 $6.41 $32,050.00
Disclosure

SEC source: 0001567619-22-018377 · doc1.xml · nonDerivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 28, 2022 Filed Oct 1, 2022 01:31 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $6.41 $0.00
Disclosure

SEC source: 0001140361-22-035562 · form4.xml · derivative · entry 3

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Ordinary Shares · 25,000 shares

Expires 2023-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.

F2 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately four months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.

Read SEC document
September 28, 2022 Filed Oct 1, 2022 01:31 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 25,000 $48.09 $1,202,250.00
Disclosure

SEC source: 0001140361-22-035562 · form4.xml · nonDerivative · entry 2

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,219

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
September 28, 2022 Filed Oct 1, 2022 01:31 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 25,000 $6.41 $160,250.00
Disclosure

SEC source: 0001140361-22-035562 · form4.xml · nonDerivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 18, 2022 Filed May 28, 2022 01:30 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $25.60 $0.00
Disclosure

SEC source: 0001140361-22-021106 · form4.xml · derivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Ordinary Shares · 15,000 shares

Expires 2032-05-18

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2023 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.

Read SEC document
April 05, 2022 Filed Apr 8, 2022 01:47 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $6.41 $0.00
Disclosure

SEC source: 0001567619-22-008265 · doc1.xml · derivative · entry 4

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Ordinary Shares · 5,000 shares

Expires 2023-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately 10 months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.

F2 · derivative.expiration_date: The option was granted on January 29, 2013, and all shares subject to the option were fully vested and exercisable January 29, 2014. The option will expire in approximately 10 months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.

Read SEC document
April 05, 2022 Filed Apr 8, 2022 01:47 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 2,369 $39.66 $93,954.07
Disclosure

SEC source: 0001567619-22-008265 · doc1.xml · nonDerivative · entry 3

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,219

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $39.51 to $40.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
April 05, 2022 Filed Apr 8, 2022 01:47 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 2,631 $39.18 $103,072.58
Disclosure

SEC source: 0001567619-22-008265 · doc1.xml · nonDerivative · entry 2

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,588

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $38.485 to $39.47, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
April 05, 2022 Filed Apr 8, 2022 01:47 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 5,000 $6.41 $32,050.00
Disclosure

SEC source: 0001567619-22-008265 · doc1.xml · nonDerivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 19, 2021 Filed May 21, 2021 21:05 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $23.97 $0.00
Disclosure

SEC source: 0001567619-21-010960 · doc1.xml · derivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Ordinary Shares · 15,000 shares

Expires 2031-05-19

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 23:45 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantEmployee Stock Option (Right to Buy) · Derivative 6,315 Not disclosed Strike: $22.85 Not disclosed
Disclosure

SEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 6

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,315

Underlying: Ordinary Shares · 6,315 shares

Expires 2027-05-18

F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share.

F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 23:45 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 12,000 Not disclosed Strike: $56.23 Not disclosed
Disclosure

SEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 5

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 12,000 shares

Expires 2027-05-18

F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 23:45 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantEmployee Stock Option (Right to Buy) · Derivative 8,426 Not disclosed Strike: $22.85 Not disclosed
Disclosure

SEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 4

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,426

Underlying: Ordinary Shares · 8,426 shares

Expires 2026-05-20

F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share.

F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 23:45 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 15,000 Not disclosed Strike: $42.50 Not disclosed
Disclosure

SEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 3

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 15,000 shares

Expires 2026-05-20

F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 23:45 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantEmployee Stock Option (Right to Buy) · Derivative 9,803 Not disclosed Strike: $22.85 Not disclosed
Disclosure

SEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 2

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,803

Underlying: Ordinary Shares · 9,803 shares

Expires 2025-05-22

F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share.

F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 23:45 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 15,000 Not disclosed Strike: $34.04 Not disclosed
Disclosure

SEC source: 0001567619-21-004315 · doc1.xml · derivative · entry 1

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 15,000 shares

Expires 2025-05-22

F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share.

Read SEC document
May 20, 2020 Filed May 22, 2020 20:39 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $11.33 $0.00
Disclosure

SEC source: 0001567619-20-011034 · doc1.xml · derivative · entry 2

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Ordinary Shares · 17,500 shares

Expires 2030-05-20

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2021 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.

Read SEC document
May 22, 2019 Filed May 24, 2019 20:08 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $9.23 $0.00
Disclosure

SEC source: 0001567619-19-012075 · doc1.xml · derivative · entry 2

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Ordinary Shares · 17,500 shares

Expires 2029-05-22

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2020 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.

Read SEC document
May 16, 2018 Filed May 18, 2018 20:16 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $16.43 $0.00
Disclosure

SEC source: 0000899243-18-013417 · doc4.xml · derivative · entry 2

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Ordinary Shares · 12,000 shares

Expires 2028-05-16

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2019 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.

Read SEC document
May 18, 2017 Filed May 19, 2017 20:05 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $56.23 $0.00
Disclosure

SEC source: 0000899243-17-013893 · doc4.xml · derivative · entry 2

COLLIER RICHARD T · CIK 0001110751 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Ordinary Shares · 12,000 shares

Expires 2027-05-18

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2018 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.